Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

medmix AG (MEDX) Stock Price & Analysis

MEDX Stock Chart & Stats

CHF 10.98CHF 0.46(4.37%)
At close: 5:14 PM GMT+1
CHF9CHF10CHF1110 Aug24 Aug7 Sep21 Sep5 Oct19 Oct2 Nov
Day’s Range
CHF 10.40 - CHF 11.08
52-Week Range
CHF 7.61 - CHF 12.36
Previous Close
CHF 10.52
Volume
N/A
Average Volume (3M)
60.75K
Market Cap
CHF 434.08M
Enterprise Value
CHF 610.90M
Total Cash (Recent Filing)
CHF 111.30M
Total Debt (Recent Filing)
CHF 319.40M
Price to Earnings (P/E)
4400.0
Beta
0.95
Next Earnings
Feb 23, 2027 (Est.)
EPS Estimate
0.42
Last Dividend Ex-Date
Apr 20, 2026
Dividend Yield
0.91%

Bulls Say, Bears Say

Bulls Say

Return To Positive Net Income

The return to positive net income shows that medmix has improved profitability after the prior-year weakness. Although earnings remain modest, restoring positive results supports internal funding, strengthens financial resilience, and provides a base for further operating improvement.

Positive Cash Generation

Positive operating and free cash flow indicate that medmix’s operations continue to convert business activity into usable funding. This supports investment, debt service, and other capital needs without relying entirely on external financing, even as cash generation remains variable.

Substantial Capital Base

A substantial and stable equity base gives medmix a durable financial foundation for serving customers and pursuing operational priorities. This provides some balance-sheet support through changing conditions, despite the company’s currently low returns on that capital.

Bears Say

Declining Revenue

Recent revenue contraction indicates a softer demand backdrop and limits the company’s ability to expand earnings through volume growth. Continued top-line weakness could reduce operating leverage, constrain investment capacity, and make the profitability recovery harder to sustain.

Thin And Fragile Margins

Very thin margins leave medmix with limited protection against weaker demand or operating pressures. The gap versus the stronger 2021 peak also suggests that the earnings recovery is not yet firmly established, increasing the risk that modest setbacks could materially affect net income.

Higher Leverage And Low Returns

Debt approaching equity reduces financial flexibility compared with prior years, while the low return on equity shows that the capital base is producing limited profits. Together, these factors can constrain future capital allocation and make balance-sheet efficiency a lasting concern.

medmix AG News

MEDX FAQ

What was medmix AG’s price range in the past 12 months?
medmix AG lowest stock price was CHF7.61 and its highest was CHF12.36 in the past 12 months.
What is medmix AG’s market cap?
medmix AG’s market cap is CHF434.08M.
When is medmix AG’s upcoming earnings report date?
medmix AG’s next earnings report is estimated for Feb 23, 2027 (not yet confirmed), which is in 112 days.
How were medmix AG’s earnings last quarter?
medmix AG released its earnings results on Jul 23, 2026. The company reported CHF0.32 earnings per share for the quarter, missing the consensus estimate of CHF0.35 by -CHF0.03.
Is medmix AG overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does medmix AG pay dividends?
medmix AG pays a Annually dividend of CHF0.1 which represents an annual dividend yield of 0.91%. See more information on medmix AG dividends here
What is medmix AG’s EPS estimate?
medmix AG’s EPS estimate is 0.42.
How many shares outstanding does medmix AG have?
medmix AG has 41,262,370 shares outstanding.
What happened to medmix AG’s price movement after its last earnings report?
medmix AG reported an EPS of CHF0.32 in its last earnings report, missing expectations of CHF0.35. Following the earnings report the stock price went down -4.01%.
Which hedge fund is a major shareholder of medmix AG?
Currently, no hedge funds are holding shares in CH:MEDX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology